Bullous Pemphigoid: A Review of its Diagnosis, Associations and Treatment, American Journal of Clinical Dermatology, vol.231, issue.2, pp.513-541, 2017. ,
DOI : 10.1159/000381143
Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies., Journal of Clinical Investigation, vol.82, issue.6, pp.1864-70, 1988. ,
DOI : 10.1172/JCI113803
URL : http://www.jci.org/articles/view/113803/files/pdf
Cloning and Primary Structural Analysis of the Bullous Pemphigoid Autoantigen BP180, Journal of Investigative Dermatology, vol.99, issue.3, pp.243-50, 1992. ,
DOI : 10.1111/1523-1747.ep12616580
URL : https://doi.org/10.1111/1523-1747.ep12616580
Tight Clustering of Extracellular BP180 Epitopes Recognized by Bullous Pemphigoid Autoantibodies, Journal of Investigative Dermatology, vol.109, issue.4, pp.573-582, 1997. ,
DOI : 10.1111/1523-1747.ep12337492
URL : https://doi.org/10.1111/1523-1747.ep12337492
BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230, J Immunol, vol.176, issue.3, pp.2015-2038, 2006. ,
Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid, Clinical Immunology, vol.128, issue.3, pp.415-441, 2008. ,
DOI : 10.1016/j.clim.2008.04.012
Incidence and Mortality of Bullous Pemphigoid in France, Journal of Investigative Dermatology, vol.132, issue.8, pp.1998-2004, 2012. ,
DOI : 10.1038/jid.2012.35
URL : https://hal.archives-ouvertes.fr/hal-00729013
Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group, Archives of Dermatology, vol.131, issue.1, pp.48-52, 1995. ,
DOI : 10.1001/archderm.131.1.48
Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts, Journal of the American Academy of Dermatology, vol.66, issue.3, pp.479-85, 2012. ,
DOI : 10.1016/j.jaad.2011.06.032
URL : http://europepmc.org/articles/pmc3883429?pdf=render
Evaluation of Clinical Criteria for Diagnosis of Bullous Pemphigoid, Archives of Dermatology, vol.134, issue.9, pp.1075-80, 1998. ,
DOI : 10.1001/archderm.134.9.1075
Bullous Pemphigoid: Physiopathology, Clinical Features and Management, Advances in Dermatology, vol.23, pp.257-88, 2007. ,
DOI : 10.1016/j.yadr.2007.07.013
Pemphigoid diseases, The Lancet, vol.381, issue.9863, pp.320-352, 2013. ,
DOI : 10.1016/S0140-6736(12)61140-4
An in Vitro Model of Immune Complex-mediated Basement Membrane Zone Separation Caused by Pemphigoid Antibodies, Leukocytes, and Complement, Journal of Investigative Dermatology, vol.78, issue.4, pp.285-90, 1982. ,
DOI : 10.1111/1523-1747.ep12507222
URL : https://doi.org/10.1111/1523-1747.ep12507222
Autoantibodies to Bullous Pemphigoid Antigen 180 Induce Dermal???Epidermal Separation in Cryosections of Human Skin, Journal of Investigative Dermatology, vol.118, issue.4, pp.664-71, 2002. ,
DOI : 10.1046/j.1523-1747.2002.01720.x
URL : https://doi.org/10.1046/j.1523-1747.2002.01720.x
A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180., Journal of Clinical Investigation, vol.92, issue.5, pp.2480-2488, 1993. ,
DOI : 10.1172/JCI116856
Humanization of autoantigen, Nature Medicine, vol.280, issue.3, pp.378-83, 2007. ,
DOI : 10.1002/1099-1387(200008)6:8<378::AID-PSC265>3.0.CO;2-Q
A Novel Active Mouse Model for Bullous Pemphigoid Targeting Humanized Pathogenic Antigen, The Journal of Immunology, vol.184, issue.4, pp.2166-74, 2010. ,
DOI : 10.4049/jimmunol.0903101
URL : http://www.jimmunol.org/content/jimmunol/184/4/2166.full.pdf
Mechanisms of Autoantibody-Induced Pathology, Frontiers in Immunology, vol.34, 2017. ,
DOI : 10.1016/j.autrev.2012.07.005
URL : http://journal.frontiersin.org/article/10.3389/fimmu.2017.00603/pdf
In vitro and in vivo models to investigate the pathomechanisms and novel treatments for pemphigoid diseases, Experimental Dermatology, vol.131, issue.12, pp.1163-70, 2017. ,
DOI : 10.1038/jid.2010.248
Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients, J Invest Dermatol, vol.122, issue.1, 2004. ,
Clinical Features and Practical Diagnosis of Bullous Pemphigoid, Immunology and Allergy Clinics of North America, vol.32, issue.2, pp.217-232, 2012. ,
DOI : 10.1016/j.iac.2012.04.002
Increased Expression of Matrix Metalloproteinase-2, Matrix Metalloproteinase-9 and Matrix Metalloproteinase-13 in Lesional Skin of Bullous Pemphigoid, International Archives of Allergy and Immunology, vol.298, issue.2, pp.104-117, 2006. ,
DOI : 10.1016/S0091-6749(96)70073-8
Respective Contribution of Neutrophil Elastase and Matrix Metalloproteinase 9 in the Degradation of BP180 (Type XVII Collagen) in Human Bullous Pemphigoid, Journal of Investigative Dermatology, vol.117, issue.5, 2001. ,
DOI : 10.1046/j.0022-202x.2001.01521.x
URL : https://hal.archives-ouvertes.fr/inserm-00153458
Innate Immune Cell???Produced IL-17 Sustains Inflammation in Bullous Pemphigoid, Journal of Investigative Dermatology, vol.134, issue.12, pp.2908-2925, 2014. ,
DOI : 10.1038/jid.2014.263
Integrating longitudinal serum IL-17 and IL-23 follow-up, along with autoantibodies variation, contributes to predict bullous pemphigoid outcome, Scientific Reports, vol.134, issue.1, 2015. ,
DOI : 10.1001/archderm.134.9.1075
Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome, Scientific Reports, vol.138, issue.1, p.4833, 2017. ,
DOI : 10.1016/j.annder.2011.01.009
URL : https://www.nature.com/articles/s41598-017-04687-5.pdf
Assessment of Bullous Pemphigoid Disease Area Index during Treatment: A Prospective Study of 30 Patients, Dermatology, vol.229, issue.2, pp.116-2210000362717, 1159. ,
DOI : 10.1159/000362717
BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid, Journal of Dermatological Science, vol.30, issue.3 ,
DOI : 10.1016/S0923-1811(02)00109-3
Correlation of clinical severity and ELISA indices for the NC16A domain of BP180 ,
Enzyme-linked immunosorbent assay using bacterial recom binant proteins of human BP230 as a diagnostic tool for bullous pemphigoid ,
DOI : 10.1016/j.jdermsci.2005.11.002
Usefulness of BP230 and BP180-NC16a Enzyme-Linked Immunosorbent Assays in the Initial Diagnosis of Bullous Pemphigoid, Archives of Dermatology, vol.147, issue.3, pp.286-91, 2011. ,
DOI : 10.1001/archdermatol.2011.23
URL : https://hal.archives-ouvertes.fr/hal-00584055
Repetitive Immunization Breaks Tolerance to Type XVII Collagen and Leads to Bullous Pemphigoid in Mice, The Journal of Immunology, vol.187, issue.3, pp.1176-83, 2011. ,
DOI : 10.4049/jimmunol.1100596
URL : http://www.jimmunol.org/content/jimmunol/187/3/1176.full.pdf
Fc?? Receptors III and IV Mediate Tissue Destruction in a Novel Adult Mouse Model of Bullous Pemphigoid, The American Journal of Pathology, vol.184, issue.8, pp.2185-96, 2014. ,
DOI : 10.1016/j.ajpath.2014.05.007
The Pathophysiology of Bullous Pemphigoid, Clinical Reviews in Allergy & Immunology, vol.115, issue.1-2, pp.67-77, 2007. ,
DOI : 10.1111/j.1346-8138.1992.tb03247.x
Pemphigoid diseases: Pathogenesis, diagnosis, and treatment, Autoimmunity, vol.35, issue.7, pp.55-70, 2011. ,
DOI : 10.1111/j.1365-2230.2009.03731.x
Oesophageal involvement in 26 consecutive patients with mucous membrane pemphigoid, British Journal of Dermatology, vol.37, issue.4, pp.1074-85, 2017. ,
DOI : 10.1016/j.dld.2004.10.005
Regulatory T cells in skin lesions and blood of patients with bullous pemphigoid, Journal of the European Academy of Dermatology and Venereology, vol.10, issue.2, pp.222-252, 2014. ,
DOI : 10.1016/j.autrev.2011.05.004
URL : https://iris.unito.it/bitstream/2318/142764/4/142764_4aperto.pdf
Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients, Archives of Dermatological Research, vol.23, issue.6, pp.639-684, 2012. ,
DOI : 10.1093/intimm/dxr020
URL : https://iris.unito.it/bitstream/2318/130892/1/Quaglino%20Circulating%20TREG%20in%20bullous%20pemphogoid%20Archives%202012_4aperto.pdf
BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid, Frontiers in Immunology, vol.35, 2017. ,
DOI : 10.1007/s10067-016-3354-2
Regulatory T Cells Suppress Inflammation and Blistering in Pemphigoid Diseases, Frontiers in Immunology, vol.10, 2017. ,
DOI : 10.1038/nrrheum.2014.105
URL : https://www.frontiersin.org/articles/10.3389/fimmu.2017.01628/pdf
Tissue resident regulatory T cells: novel therapeutic targets for human disease, Cellular & Molecular Immunology, vol.480, issue.5, pp.543-52, 2015. ,
DOI : 10.1038/nature09114
URL : http://www.nature.com/cmi/journal/v12/n5/pdf/cmi201523a.pdf
The ageing immune system: is it ever too old to become young again?, Nature Reviews Immunology, vol.181, issue.1, pp.57-6210, 1038. ,
DOI : 10.1210/en.139.10.4120
Severity and Phenotype of Bullous Pemphigoid Relate to Autoantibody Profile Against the NH2- and COOH-Terminal Regions of the BP180 Ectodomain, Journal of Investigative Dermatology, vol.119, issue.5, pp.1065-73, 2002. ,
DOI : 10.1046/j.1523-1747.2002.19529.x
Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients, British Journal of Dermatology, vol.108, issue.5, pp.1004-1014, 2004. ,
DOI : 10.1046/j.1365-2133.1998.02396.x
Structural proteins of the dermal-epidermal junction targeted by autoantibodies in pemphigoid diseases, Experimental Dermatology, vol.228, issue.Pt 17, pp.1154-62, 2017. ,
DOI : 10.1111/j.0022-202X.2005.23702.x